Thailand Successfully Hosts Its First WIC APAC Webinar, Drawing Strong Regional Interest in Personalized Cancer Vaccines
- May 18, 2026
- admin@narisara
- 0
TTCI Representative Highlights CAR-T Cell Therapy Roadmap at the 74th JSTMCT Annual Meeting in Yokohama
May 16, 2026
BANGKOK, THAILAND — The Thailand Hub of Talents in Cancer Immunotherapy, in collaboration with the World Immunotherapy Council (WIC), successfully hosted its first-ever regional session under the WIC APAC Regional Webinar Series on Friday, May 15, 2026.
The milestone webinar, titled "Personalized Cancer Vaccines: A New Frontier in Thailand’s Fight Against Cancer," marked a significant step forward for the country as it took center stage to lead the scientific dialogue on advanced precision medicine within the Asia-Pacific region.
Pioneering Innovations on Stage The webinar featured a keynote presentation by Dr. Trairak Pisitkun, MD, a renowned expert from the Faculty of Medicine, Chulalongkorn University. Dr. Trairak shared groundbreaking insights into personalized cancer vaccine innovations, the landscape of precision medicine in Thailand, and the crucial journey of translating bench research into real-world clinical applications.
The virtual event was expertly guided by co-moderators Dr. Joe Yeong, MD, PhD, and TTCI’s very own Dr. Nattiya Hirankar, MD, PhD, driving a seamless exchange of complex medical concepts.
As Thailand's debut hosting event in this regional series, the webinar attracted phenomenal attention from the international medical and scientific communities, demonstrating both strong attendance and remarkably deep engagement
The data revealed a highly specialized audience profile, ensuring that the knowledge transferred directly impacts the front lines of cancer research and clinical care
This successful debut not only showcases Thailand's rapidly growing capabilities in cancer immunotherapy on an international platform but also reinforces TTCI’s commitment to fostering high-level technology promotion, academic exchange, and cross-border scientific collaboration.
The milestone webinar, titled "Personalized Cancer Vaccines: A New Frontier in Thailand’s Fight Against Cancer," marked a significant step forward for the country as it took center stage to lead the scientific dialogue on advanced precision medicine within the Asia-Pacific region.
Pioneering Innovations on Stage The webinar featured a keynote presentation by Dr. Trairak Pisitkun, MD, a renowned expert from the Faculty of Medicine, Chulalongkorn University. Dr. Trairak shared groundbreaking insights into personalized cancer vaccine innovations, the landscape of precision medicine in Thailand, and the crucial journey of translating bench research into real-world clinical applications.
The virtual event was expertly guided by co-moderators Dr. Joe Yeong, MD, PhD, and TTCI’s very own Dr. Nattiya Hirankar, MD, PhD, driving a seamless exchange of complex medical concepts.
As Thailand's debut hosting event in this regional series, the webinar attracted phenomenal attention from the international medical and scientific communities, demonstrating both strong attendance and remarkably deep engagement
The data revealed a highly specialized audience profile, ensuring that the knowledge transferred directly impacts the front lines of cancer research and clinical care
This successful debut not only showcases Thailand's rapidly growing capabilities in cancer immunotherapy on an international platform but also reinforces TTCI’s commitment to fostering high-level technology promotion, academic exchange, and cross-border scientific collaboration.
Tags: Chulalongkorn University




